June 23 (Reuters) - Carisma Therapeutics Inc ( CARM ):
* CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE
MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL
THERAPIES FOR ORTHOPEDIC DISEASES
* CARISMA THERAPEUTICS INC ( CARM ) - ORTHOCELLIX TO MERGE INTO
WHOLLY-OWNED SUBSIDIARY OF CARISMA
* CARISMA THERAPEUTICS INC ( CARM ) - ORTHOCELLIX STOCKHOLDER TO OWN
90% OF
COMBINED COMPANY POST-MERGER
* CARISMA THERAPEUTICS INC ( CARM ) - TO BE RENAMED ORTHOCELLIX AND
TRADE
UNDER TICKER OCLX
* CARISMA THERAPEUTICS ( CARM ): TO ISSUE TO PRE-MERGER ORTHOCELLIX
STOCKHOLDER SHARES OF CO'S COMMON STOCK AS MERGER CONSIDERATION
Source text:
Further company coverage: